Chemical Compound
Fluvoxamine maleate; 2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethanamine (Z)-butenedioate; 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1); 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1); Avoksin; Avoxin; DU 23000; Depromel; Dumirox; Faverin; Faverin 50; Faverine; Fevarin; Floxyfral; Luvox; MK 264; Maveral; NSC 309469
CAS Registry Number
61718-82-9
Primary record
Fluvoxamine maleate; 2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethanamine (Z)-butenedioate; 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1); 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1); Avoksin; Avoxin; DU 23000; Depromel; Dumirox; Faverin; Faverin 50; Faverine; Fevarin; Floxyfral; Luvox; MK 264; Maveral; NSC 309469
- 库存
- 2,217 克
- 纯度
- 99.2 %
- CAS
- 61718-82-9
化合物标识与属性
- CAS
- 61718-82-9
- PubChem CID
- 9560989
- SMILES
- COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F.C(=C\C(=O)O)\C(=O)O
- Canonical SMILES
- COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\C(=O)O
名称与同义词
- FLUVOXAMINE MALEATE
- Luvox
- Fevarin
- Faverin
- fluvoxamine
- Floxyfral
- 61718-82-9
- Luvox CR
- Fluoxamine
- Fluroxamine
- Fluvoxamina
- Fluvoxaminum
- Depromel
- Dumirox
- Maveral
- Fluvoxaminemaleate
- Fluvoxamine.maleate
- Fluvoxamine (maleate)
- Faverin 50
- (E)-Fluvoxamine Maleate
- Faverin 100
- Fluvoxamine hydrogenmaleate
- Luvox (TN)
- Fluvoxamine maleate [USAN]
- Fluvoxamine Maleate RS
- Fluvoxamine maleate CRS
- RefChem:56866
- Fluvoxamine [INN:BAN]
- 5LGN83G74V
- C19H25F3N2O6
- UNII-5LGN83G74V
- Fluvoxamine maleate, solid
- DU23000
- Fluvoxaminum [INN-Latin]
- MFCD00269809
- D0M5JI
- UNII-O4L1XPO44W
- Fluvoxamina [INN-Spanish]
- CHEMBL1409
- Fluvoxamine Maleate, (E)-
- SCHEMBL35225
- DTXSID3042558
- Fluvoxamine maleate [USAN:USP]
- MLS000028469
- MLS000758271
- MLS001076285
- MLS001304717
- MLS001401391
- SME 3110
- DU-23000
- NSC-759602
- LFMYNZPAVPMEGP-PIDGMYBPSA-N
- MK-264
- CHEBI:5139
- HY-B0103AR
- orb1309842
- DTXCID1022558
- FLUVOXAMINE MALEATE [MI]
- NSC 309469
- ERK5-1P04
- HY-B0103A
- FLUVOXAMINE MALEATE [JAN]
- C15H21F3N2O2
- Fluvoxamine (maleate) (Standard)
- Fluvoxamine maleate (JP18/USP)
- C15H21F3N2O2.C4H4O4
- GLXC-07697
- HMS1571G11
- HMS2098G11
- HMS3261D11
- HMS3412A13
- HMS3676A13
- HMS3715G11
- HMS3884K11
- HMS5079B13
- Pharmakon1600-01505604
- FLUVOXAMINE MALEATE [VANDF]
- FLUVOXAMINE MALEATE [MART.]
- SME-3110
- Tox21_500495
- EBC-13000
- FLUVOXAMINE MALEATE [USP-RS]
- FLUVOXAMINE MALEATE [WHO-DD]
- Fluvoxamine Maleate Impurity Standard
- HB2138
- NSC309469
- NSC759602
- s1336
- AKOS015961142
- Fluvoxamine for system suitability CRS
- AC-9541
- C15-H21-F3-N2-O2
- CCG-213494
- CID9560989
- CS-1839
- FF02412
- NSC 759602
- NSC-309469
- (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate
- Fluvoxamine maleate - Bio-X trade mark
- FLUVOXAMINE MALEATE [ORANGE BOOK]
- NCGC00093897-01
- NCGC00093897-02
- NCGC00261180-01
- AN-39241
- AS-11790
- BF164482
- CPD000466268
- DU 23000
- FLUVOXAMINE MALEATE [EP MONOGRAPH]
- SAM001246977
- SMR000058449
- SMR000466268
- SMR000653482
- SY066847
- FLUVOXAMINE MALEATE [USP MONOGRAPH]
- AB2000054
- LS-102000
- TL8003932
- EU-0100495
- F0858
- FT-0626496
- ST24035070
- 54739-20-7
- C15-H21-F3-N2-O2.C4-H4-O4
- D00824
- D70454
- F 2802
- J90043
- EN300-1692902
- 739F183
- A833394
- SR-01000075613
- (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
- A1206352
- SR-01000075613-1
- SR-01000075613-3
- SR-01000075613-4
- SR-01000075613-6
- (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl)-1-pent
- (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate
- Q27262521
- 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1)
- 5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate
- 54739-18-3
- Fluvoxamine.maleate, 1mg/ml in Methanol (as free base)
- Z2568647847
- 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1)
- Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard
- Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard
- (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine
- (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1)
- 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1)
- Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard
- (1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime
- (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate
- (E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate
- 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-
- 5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one (E)-O-(2-aminoethyl)oxime monomaleate
- 5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate
- Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard
- Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material
- Fluvoxamine maleate, 98%, a selective serotonin (5-HT) reuptake inhibitor (SSRI) - 1G 1g
- Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
- maleic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
- maleic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
- (2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; but-2-enedioic acid
- (2Z)-But-2-enedioic acid--2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine (1/1)
- (Z)-2-butenedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
- (Z)-but-2-enedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
- 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime,(E)-, (Z)-2-butenedioate (1:1)
- 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-,O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1)
- 5-METHOXY-4'-(TRIFLUOROMETHYL)VALEROPHENONE-(E)-O-(2-AMINOETHYL)OXIME MALEATE (1:1)
- Fluvoxamine maleate; 2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethanamine (Z)-butenedioate; 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1); 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1); Avoksin; Avoxin; DU 23000; Depromel; Dumirox; Faverin; Faverin 50; Faverine; Fevarin; Floxyfral; Luvox; MK 264; Maveral; NSC 309469